US FDA authorizes Lilly COVID-19 drug

The US Food and Drug Administration (FDA) said on Friday it had granted emergency use authorization to Eli Lilly and Co's COVID-19 antibody drug for the treatment of patients with mild to moderate disease who are 12 years and older.